Physician profile

Paari Dominic

Clinical Cardiac Electrophysiology · Iowa City, IA

NPI 1134328958

$82,789.96

in general payments reported to CMS, 2019-2025

33 companies · $46K in 2025

The $46K reported for 2025 was more than what 95% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

See the full distribution for Clinical Cardiac Electrophysiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$23,865.63
Consulting Fee$18,425.00
Food and Beverage$15,062.10
Travel and Lodging$9,973.65

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $35,453.78 2019-2025 Ingevity+, General - Ep, Farapulse
Biosense Webster, INC. $28,142.81 2019-2025 Carto 3, Qdot Micro, Qdot Micro Catheter
Abbott Laboratories $7,972.00 2019-2025 Aveir, Ensite, Gallant
Atricure, INC. $1,477.17 2019-2024
Medical Device Business Services, INC. $1,341.48 2022-2024 Carto 3
Medtronic, INC. $1,203.37 2021-2025 Linq II, Micra, Tyrx
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $966.49 2019-2025 Lifevest
Zoll Respicardia, INC. $915.29 2021-2025 Remede System
Impulse Dynamics (USA) INC. $870.47 2022-2025 Optimizer, Optimizer
Itamar Medical INC $728.28 2021-2025 Watchpatone
Cardiva Medical, INC. $576.45 2019-2025 Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f
Medtronic Vascular, INC. $522.04 2019-2020
Abiomed $490.23 2021-2024 Impella
Philips North America LLC $485.09 2021-2025 (9520) Igt Devices Undivided, Lm Undivided, (Am5) Lead Management
Pfizer INC. $288.89 2019-2022
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Biotronik INC. $278.24 2021-2025 Amvia Edge
Elutia, INC. $272.65 2020-2024 Ecm Patch,Pouch
Janssen Pharmaceuticals, INC $143.85 2019-2022
Astrazeneca Pharmaceuticals LP $95.73 2019-2022
Inspire Medical Systems, INC. $85.33 2023 Inspire
Preventice Services, LLC $81.66 2021
Sanofi-Aventis U.S. LLC $67.76 2019-2022
E.R. Squibb & Sons, L.L.C. $61.22 2019-2022
Regeneron Healthcare Solutions, INC. $38.05 2019
Irhythm Technologies, INC. $37.17 2020
Volta Medical INC $36.60 2024 Vx1
Novartis Pharmaceuticals Corporation $31.62 2021-2022
Bardy Diagnostics, INC. $27.81 2019-2020
Portola Pharmaceuticals, LLC $26.18 2019
Shockwave Medical, INC $24.59 2025
Penumbra, INC. $18.88 2025 Penumbra System
Merck Sharp & Dohme LLC $14.78 2022
Terumo Medical Corporation $14.00 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Paari Dominic

$82,789.96

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $46K reported for 2025 was more than what 95% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/652002/paari-dominic

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.